Australië - Engels - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide (frusemide) -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide (frusemide) -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - furosemide (frusemide) -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hydrochlorothiazide,irbesartan -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hydrochlorothiazide,irbesartan -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hydrochlorothiazide,irbesartan -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - cabazitaxel acetone solvate -

Australië - Engels - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - adenosine, quantity: 3 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - therapeutic indications: rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory by-pass tracts (wolff-parkinson-white syndrome). diagnostic indications: aid to diagnosis of broad or narrow complex supraventricular tachycardias. although adenocor is not effective in converting atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of av conduction helps diagnosis of atrial activity. in this respect adenosine should be used as an adjunct to, but not a replacement for, clinical and ecg observations. it should be only used when, despite all diagnostic attempts, doubt still persists. improved diagnostic sensitivity of intracavity electrophysiological investigations

Zuid-Afrika - Engels - South African Health Products Regulatory Authority (SAHPRA)

sanofi-aventis south africa (pty) ltd - tablet - see ingredients - each tablet contains felodipine 2,5 mg ramipril 2,5 mg

Japan - Engels - すりの適正使用協議会 RAD-AR Council, Japan

sanofi k.k. - spiramycin - white tablet, diameter: 10 mm, thickness: 5.5 mm